Tariffs
-
Drug Stocks Are Starting To Trade Their Factory Maps, Not Just Their Pipelines
A fresh U.S. tariff clock, Roche’s June 4 backlash, Takeda’s global manufacturing footprint and Samsung Biologics’ new Maryland site all point to the same message: in pharma, location is becoming a market variable again.
-
Tariffs Are Becoming a Traceability Trade, Not a Blanket Exporter Panic
Washington’s new forced-labor tariff proposal hit Japan, Korea, and Europe in one stroke, but the exemption list says traders should watch supply-chain compliance risk more closely than headline fear.
-
The New Hotspot Is the Metals Trade Reset: U.S. Tariff Tweaks, Japan’s Steel Probe and Korea’s Margin Squeeze
A fresh policy burst across Washington, Tokyo, Brussels and Seoul has turned steel, aluminum and copper exposure into a cross-market pricing-power trade rather than a simple commodity story.